MABEPA IVS: Financial statements 2019
CVR: 40230157
Source: annual report 2019, Danish Business Authority
04/02/2019 – 31/12/2019
MABEPA IVS (CVR 40230157) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 55,684 and a net result of DKK 2,022. The profit margin was 3.6%. Equity in the 2019 report amounted to DKK 6,000. The solvency ratio was 100%.
- Revenue
- DKK 55,684
- Gross Profit
- DKK 5,717
- Profit/Loss
- DKK 2,022
- Equity
- DKK 6,000
- Total Assets
- DKK 6,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of February 4, 2019, Patrick Elbæk Kjærsgaard is registered as adm. dir. of MABEPA IVS.
MABEPA IVS was founded on February 4, 2019.
About MABEPA IVS
MABEPA IVS was a Danish company of the type Iværksætterselskab based in Glostrup, founded in 2019. The company has been dissolved on 8 September 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. In 2020, the company reported revenue of DKK 262,368 and a net result of DKK 3,220 compared with DKK 2,022 the year before. Equity in the 2020 report amounted to DKK 3,220.